Works matching IS 00278874 AND DT 2012 AND VI 104 AND IP 2
Results: 24
Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
- Published in:
- 2012
- By:
- Publication type:
- journal article
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 93, doi. 10.1093/jnci/djr511
- By:
- Publication type:
- Article
IN THIS ISSUE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 81, doi. 10.1093/jnci/djr551
- Publication type:
- Article
InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 147
- By:
- Publication type:
- Article
JAPANESE JOURNAL OF CLINICAL ONCOLOGY.
- Published in:
- 2012
- Publication type:
- Table of Contents
EDITORIAL BOARD.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. NP, doi. 10.1093/jnci/djs016
- Publication type:
- Article
Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 114, doi. 10.1093/jnci/djr486
- By:
- Publication type:
- Article
Drug Approvals 2011: Focus on Companion Diagnostics.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 84, doi. 10.1093/jnci/djr552
- By:
- Publication type:
- Article
YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 133, doi. 10.1093/jnci/djr512
- By:
- Publication type:
- Article
Study Shows no Evidence of a Mortality Benefit to PSA Screening.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. NP, doi. 10.1093/jnci/djs005
- Publication type:
- Article
Next Steps in Clinical Trial Redesign.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 90, doi. 10.1093/jnci/djr550
- By:
- Publication type:
- Article
Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections.
- Published in:
- 2012
- By:
- Publication type:
- Letter
ALK Gene Amplified in Most Inflammatory Breast Cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 87, doi. 10.1093/jnci/djr553
- By:
- Publication type:
- Article
Response: Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections.
- Published in:
- 2012
- By:
- Publication type:
- Letter
StatBite Drugs In Development By Therapeutic Area (2010).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 86, doi. 10.1093/jnci/djr563
- Publication type:
- Article
TABLE OF CONTENTS.
- Published in:
- 2012
- Publication type:
- Table of Contents
Finding Ovarian Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Predicting the Value of Indexing Symptoms for Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. NP, doi. 10.1093/jnci/djs013
- Publication type:
- Article
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 125
- By:
- Publication type:
- Article
Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 159, doi. 10.1093/jnci/djr490
- By:
- Publication type:
- Article
Cover.
- Published in:
- 2012
- Publication type:
- Table of Contents
Adoptive Immunotherapy Poised To Deliver on Decades-Old Promise.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 88, doi. 10.1093/jnci/djr554
- By:
- Publication type:
- Article